Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	196
Hyperplasia of prostate (N40)	129
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	119
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	110
Calculus of kidney and ureter - Calculus of ureter (N20.1)	70
Cystitis (N30.0)	64
Malignant neoplasm of prostate (C61)	62
Unspecified haematuria (R31)	62
Acute tubulo-interstitial nephritis (N10)	56
Calculus of kidney and ureter - Calculus of kidney (N20.0)	50

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	478
(5-98k.0)	453
Computed tomography (CT) of the abdomen without contrast medium (3-207)	335
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	264
Computed tomography of the abdomen with contrast medium (3-225)	223
Revision operations (5-983)	195
Insertion, exchange or removal of a ureteral stent (8-137.00)	190
Insertion, exchange or removal of a ureteral stent (8-137.10)	172
Computed tomography of the chest with contrast medium (3-222)	170
Computed tomography of the pelvis with contrast medium (3-226)	156

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Chronische obstruktive Lungenerkrankung (COPD)

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ06	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
141	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
102	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
102	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Lectureships / teaching posts at colleges and universities
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)